JPMorgan Raises its Price Target on UnitedHealth Group (UNH)

UnitedHealth Group Incorporated (NYSE:UNH) is one of the 7 Best Longevity Stocks to Buy Now.

On June 8, 2026, JPMorgan raised the firm’s price target on UnitedHealth Group Incorporated (NYSE:UNH) to $466 from $420 and maintained an Overweight rating on the shares. JPMorgan updated its healthcare service models.

On the same day, Mizuho raised the firm’s price target on UnitedHealth Group Incorporated (NYSE:UNH) to $460 from $440 and maintained an Outperform rating on the shares. Mizuho said the managed care sector is entering a “more stable and predictable” policy environment, with policy-related surprises likely to moderate from the elevated levels of the past three years. The firm said this should let investors focus on company fundamentals, pricing recovery, and embedded earnings power.

JPMorgan Raises its Price Target on UnitedHealth Group (UNH)

Pixabay/Public domain

On June 4, 2026, BofA analyst Kevin Fischbeck upgraded UnitedHealth Group Incorporated (NYSE:UNH) to Buy from Neutral with a price target of $450, up from $420. Fischbeck said incoming data points make it harder to view the strong Q1 as purely tied to weak flu and storms, and said UnitedHealth should lead a broader managed care rally if utilization trends continue to moderate.

UnitedHealth Group Incorporated (NYSE:UNH) operates as a health care company in the United States and internationally.

While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UNH and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1